Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination

Study Overview
=================
Brief Summary
-----------------
This is a minimal risk, anonymous, convenience sample, social behavioral study using qualitative descriptive survey methods. It is to ascertain community member, physician, resident and medical student perspectives regarding Human Papillomavirus (HPV) infection, associated diseases and to identify barriers which prevent these groups from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection. The research is focused on these questions: Do community members understand the ease of transmission of the HPV virus in males 9-26? Do community members, physicians, residents and medical students have knowledge of the associated diseases that may occur with the HPV virus infection in males age 9-26? Do community members, physicians, residents and medical students know the ages in which males should receive the HPV vaccine three-shot series? What barriers prevent community members and physicians, residents and medical students from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection?

Detailed Description
-----------------
This is a minimal risk, anonymous, convenience sample, social behavioral study using qualitative descriptive survey methods. It is to ascertain community member, physician, resident and medical student perspectives regarding Human Papillomavirus (HPV) infection, associated diseases and to identify barriers which prevent these groups from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection. The research is focused on these questions: Do community members understand the ease of transmission of the HPV virus in males 9-26? Do community members, physicians, residents and medical students have knowledge of the associated diseases that may occur with the HPV virus infection in males age 9-26? Do community members, physicians, residents and medical students know the ages in which males should receive the HPV vaccine three-shot series? What barriers prevent community members and physicians, residents and medical students from ensuring that males 9-26 receive the three-shot vaccine series to prevent HPV infection?

Official Title
-----------------
Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and Vaccination

Conditions
-----------------
Papillomavirus Infections, Health Behavior, Attitude of Health Personnel, Human Papilloma Virus, Male

Intervention / Treatment
-----------------
* Other: Survey


Participation Criteria
=================
Eligibility Criteria
-----------------
Community Participants Inclusion All visitors to the Pediatric or Internal Medicine University Health Shreveport Clinics willing to complete a survey Community Study Exclusion Those do not wish to participate in the study Those who English is not their first language Clinical Faculty, Resident, and Medical Student Study Inclusion All Louisiana State University Shreveport Health Clinical Faculty, Resident, and Medical Student Inclusion willing to to complete the online survey. Clinical Faculty, Resident, and Medical Student Study Exclusion Any LSU Health Shreveport Clinical Faculty, Resident, and Medical Student which declines to take the survey or do not attempt to complete it.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Community Group Survey<br>Community members coming into the University Health Shreveport Ambulatory Care Facility. | Other: Survey<br>* Clinical Faculty and community will be given a survey to define issues preventing HPV Vaccination<br>|
| Physician Group Survey<br>Physicians affiliated with LSU Health Shreveport School of Medicine | Other: Survey<br>* Clinical Faculty and community will be given a survey to define issues preventing HPV Vaccination<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Barriers to HPV Vaccination | What are the barriers which prevent community members and physicians, residents and medical students from ensuring that males age 9-26 are vaccinated with the HPV three-shot vaccination. | 60 days | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Knowledge pertaining to ease of Human Papillomavirus transmission. | Do community members and physicians understand the ease of HPV transmission? | 60 days | 
| Knowledge of Associated HPV diseases | Do community member and physicians know the associated HPV diseases? | 60 days | 
| Knowledge of age in which males should be vaccinated against HPV. | Do community member and physicians know the age in which males should be vaccinated against HPV? | 60 days | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
HPV, Human Papillomavirus Vaccine, Patient Acceptance, Physician Comfort, Male Vaccination, HPV Associated Cancers